Augustine Asset Management’s GSK GSK Stock Holding History

Augustine Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,068	Closed	-$741K	–	71
2017 Q1	$741K	Buy	14,068 +2,684	+24%	+$136K	0.46%	47
2016 Q4	$547K	Sell	11,384 -2,544	-18%	-$126K	0.41%	44
2016 Q3	$750K	Buy	13,928 +4,668	+50%	+$256K	0.55%	42
2016 Q2	$501K	Buy	+9,260	New	+$488K	0.4%	48
2015 Q4	–	Sell	-13,844	Closed	-$665K	–	60
2015 Q3	$665K	Sell	13,844 -402	-3%	-$20.9K	0.51%	35
2015 Q2	$741K	Sell	14,246 -32	-0.2%	-$1.8K	0.55%	35
2015 Q1	$843K	Buy	14,278 +4	+0%	+$229	0.59%	33
2014 Q4	$762K	Sell	14,274 -226	-2%	-$12.6K	0.49%	40
2014 Q3	$833K	Buy	14,500 +466	+3%	+$28.6K	0.53%	41
2014 Q2	$938K	Buy	14,034 +40	+0.3%	+$2.71K	0.6%	41
2014 Q1	$935K	Buy	13,994 +1,598	+13%	+$108K	0.65%	38
2013 Q4	$827K	Sell	12,396 -3,496	-22%	-$227K	0.49%	42
2013 Q3	$997K	Buy	15,892 +488	+3%	+$31.4K	0.69%	38
2013 Q2	$962K	Buy	+15,404	New	+$978K	0.66%	41

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Augustine Asset Management's GSK Position: Q2 2017 in Review

Augustine Asset Management sold out of GSK (GSK) in Q2 2017, closing a stake of 14,068 shares — an estimated $741K sold.

Augustine Asset Management first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $997K in Q3 2013. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Augustine Asset Management reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
Augustine Asset Management sold 14,068 GSK shares in Q2 2017, an estimated $741K.
Augustine Asset Management first reported a position in GSK in Q2 2013 and held it in 14 quarters.
Augustine Asset Management's GSK position peaked at $997K in Q3 2013.
779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Augustine Asset Management's 13F filing for Q2 2017, filed 19 Jul 2017.